Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Mental health

NICE depression advice could 'seriously impede' care, say experts

Leading mental health experts have challenged draft guidelines from NICE, on the grounds that they could potentially cause clinical harm.

MP Norman Lamb giving a speech

Source: Andrew Matthews/PA Archive/PA Images

Norman Lamb, MP for the Liberal Democrats, previously requested the National Institute for Health and Care Excellence to respond to the stakeholders’ concerns; however, the changes that were made have been described as “cosmetic”, and the guidance “not fit for purpose”

The latest National Institute for Health and Care Excellence (NICE) draft guidelines on adult depression are “not fit for purpose”, say leading mental health experts.

In a position statement to NICE, a coalition of 14 organisations, including the Royal College of Psychiatrists, British Psychological Society and charity Mind, said the draft guidelines on the Recognition and Management of Depression in Adults were underpinned by a flawed methodology, a lack of transparency and several inconsistencies.

They added that, if the guidelines were published as they were, it could “seriously impede the care of millions of people in the UK suffering from depression, potentially even causing clinical harm”.

The coalition was formed after a number of stakeholders to the NICE review process expressed concerns about the draft guidelines, which were published in July 2017.

The issue was then passed on to Norman Lamb, MP for the Liberal Democrats, and in February 2018 an Early Day Motion was tabled and 23 MPs signed a cross-party letter to NICE, asking it to respond to the stakeholders’ concerns and hold a second consultation.

After a meeting in April 2018, NICE agreed to a second four-week consultation, which ended on 12 June 2018. However, according to the coalition, the changes made were only “cosmetic” and the guidance was still not fit for purpose.

As a result, the group is now demanding a full revision of the guidelines. It has spelled out six amendments that, it says, must be undertaken before the draft is published, including conducting a proper analysis of one- and two-year follow-up data from trials and carrying out a systematic review of primary studies of service-user experience.

Mark Baker, director of the NICE centre for guidelines, said the committee planned to meet soon to review and discuss the comments received, and would be responding in due course.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205039

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • MP Norman Lamb giving a speech

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.